pharmaphorum2d
AZ's lupus drug Saphnelo cleared in EU, challenging GSK's Benlysta
Saphnelo (anifrolumab) is the first biologic drug for SLE to be approved in Europe that is not restricted to patients with a high degree of disease activity, according to AZ, which also notes it ...
pharmaphorum2d
UCB, Biogen lupus drug scores in phase 3 trial
with newer medicines like GSK's Benlysta (belimumab), AstraZeneca's Saphnelo (anifrolumab), and Otsuka's Lupkynis (voclosporin). For Biogen, dapirolizumab pegol is part of a push into the ...
FierceBiotech5d
Drug discovery pact between Charles River and Valo Health nets potential lupus asset for Flagship’s Pioneering Medicines
This disease is primarily treated with off-label drugs or newer meds in the form of GSK's Benlysta and AstraZeneca's Saphnelo. The most common form of the disease is systemic lupus erythematosus ...
Healthline5d
The Difference Between Rheumatoid Arthritis (RA) and Lupus
Rheumatoid arthritis (RA) and lupus both cause joint pain and stiffness. Despite some similarities, it’s easy for doctors to distinguish them. RA has more debilitating effects on the joints ...